• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov15
BTIG Maintains Buy Rating on Gain Therapeutics
17:32
Nov13
Gain Therapeutics released FY2025 9 Months Earnings on November 12 (EST), with actual revenue of USD 0 and EPS of USD -0.5003
04:00
Gain Therapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1509 (forecast USD -0.165)
04:00
Oct17
Ram Selvaraju Maintains Buy Rating on Gain Therapeutics
10:31
Oct14
Gain Therapeutics Discusses Latest Advancements of Parkinson's Drug GT-02287
21:06
Oct7
McCormick covers and recommends healthcare industry stocks
12:36

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -5.284 M, EPS -0.1509

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -5.809 M, EPS -0.1914

May14
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -4.53 M, EPS -0.1579

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FOXX
3.630
+79.62%
+1.610
MNDR
4.790
+57.57%
+1.570
NVVE
0.2500
+52.35%
+0.086
IVDA
0.9626
+47.98%
+0.286
DVLT
2.525
+45.11%
+0.765
PTN
21.000
+44.93%
+6.625
SEVNR
0.0389
+39.93%
+0.011
CCTG
0.2242
+35.63%
+0.063
BEAGR
0.3990
+32.56%
+0.098
OSRH
0.6001
+31.60%
+0.138
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy